Heidelberg Epignostix is a pioneering start-up led by a dedicated team of DNA methylation-based tumor categorization experts.
Heidelberg Epignostix has raised $4.6M in total funding. The most recent round was Seed. The last funding was announced in July 2024.
Heidelberg Epignostix's investors include HTGF (High-Tech Gruenderfonds), Carma Fund, Start-up BW Innovation Fonds, LBBW VC.
Heidelberg Epignostix is headquartered in Heidelberg, Germany.
Heidelberg Epignostix is a pioneering start-up led by a dedicated team of DNA methylation-based tumor categorization experts.
Heidelberg Epignostix is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Heidelberg Epignostix — Funding & Investors." VCBacked, July 2, 2024, https://www.vcbacked.co/company/heidelberg-epignostix. Accessed August 1, 2026.
VCBacked. (2024). Heidelberg Epignostix — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/heidelberg-epignostix
{{cite web |title=Heidelberg Epignostix — Funding & Investors |url=https://www.vcbacked.co/company/heidelberg-epignostix |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated